Page last updated: 2024-09-03

rhenium-186 hedp and Neoplasms

rhenium-186 hedp has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Cheng, A; Dong, M; Yin, D; Zhang, Y1
de Klerk, JM; Lam, MG; van Rijk, PP; Zonnenberg, BA1

Reviews

1 review(s) available for rhenium-186 hedp and Neoplasms

ArticleYear
Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
    Anti-cancer agents in medicinal chemistry, 2007, Volume: 7, Issue:4

    Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Humans; Medical Oncology; Models, Chemical; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Strontium; Treatment Outcome

2007

Trials

1 trial(s) available for rhenium-186 hedp and Neoplasms

ArticleYear
The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:2

    Topics: Blood Cell Count; Bone Neoplasms; Electrocardiography; Etidronic Acid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Pain; Pain Measurement; Palliative Care

2011